Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9177 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.913 |
High Similarity |
NPD6959 |
Discontinued |
0.8848 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8758 |
High Similarity |
NPD7819 |
Suspended |
0.865 |
High Similarity |
NPD7768 |
Phase 2 |
0.8642 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8634 |
High Similarity |
NPD7411 |
Suspended |
0.8608 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8571 |
High Similarity |
NPD4380 |
Phase 2 |
0.8512 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8512 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8512 |
High Similarity |
NPD6166 |
Phase 2 |
0.8494 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8491 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8485 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8462 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8397 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8397 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8363 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8363 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8354 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8303 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8263 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8246 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8229 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8229 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8217 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8212 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8208 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8204 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8202 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8199 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.8193 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8161 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8153 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.815 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8114 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8103 |
Intermediate Similarity |
NPD7472 |
Approved |
0.807 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8068 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8047 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8025 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8024 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8013 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8011 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7975 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7955 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.795 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7929 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7901 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7886 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7885 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7882 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7879 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7865 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7844 |
Intermediate Similarity |
NPD3226 |
Approved |
0.784 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7831 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7831 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7824 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7818 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7818 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7818 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7799 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7798 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7791 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.779 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7778 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7778 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7764 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7764 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7758 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7756 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7738 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7713 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7713 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7713 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7713 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7713 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7713 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7713 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7711 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7702 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7684 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7668 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7661 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7654 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7633 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7619 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7617 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7607 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7593 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7593 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.759 |
Intermediate Similarity |
NPD7801 |
Approved |
0.759 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.759 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7584 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7569 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7556 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7553 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7546 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7546 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7546 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7546 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7542 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7541 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.754 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.754 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7539 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7538 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7538 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD920 |
Approved |
0.7513 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7513 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD2344 |
Approved |
0.75 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD1247 |
Approved |
0.75 |
Intermediate Similarity |
NPD5401 |
Approved |
0.747 |
Intermediate Similarity |
NPD7003 |
Approved |
0.747 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7458 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7458 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7457 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7447 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7447 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7416 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7399 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7396 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7381 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.736 |
Intermediate Similarity |
NPD5710 |
Approved |
0.736 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7358 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7353 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7344 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7341 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7321 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7312 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7308 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7293 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7288 |
Intermediate Similarity |
NPD919 |
Approved |
0.7282 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7282 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7267 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7262 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7257 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7257 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7255 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD943 |
Approved |
0.7215 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7211 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7211 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7208 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7207 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7207 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD37 |
Approved |
0.7198 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7195 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7191 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7175 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7175 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7175 |
Intermediate Similarity |
NPD4965 |
Approved |
0.716 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7135 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7134 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7127 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7125 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7117 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7113 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7102 |
Intermediate Similarity |
NPD7577 |
Discontinued |
0.7091 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7083 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7071 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.7066 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7044 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7043 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7022 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7019 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7006 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7005 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.7
|
Intermediate Similarity |
NPD8059 |
Phase 3 |